Skip to main content
Veterinary Medicines

Nafpenzal DC Intramammary Suspension

Not authorised
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
  • Nafcillin sodium

Identifikazzjoni tal-prodott

Isem tal-mediċina:
Nafpenzal DC Intramammary Suspension
Sustanza attiva:
Metodu ta’ amministrazzjoni:
  • Użu intramammarju

Dettalji tal-prodott

Sustanza attiva / Qawwa:
  • Disponibbli biss fi English
    300.00
    milligram(s)
    /
    1.00
    Syringe
  • Disponibbli biss fi English
    116.81
    milligram(s)
    /
    1.00
    Syringe
  • Disponibbli biss fi English
    105.31
    milligram(s)
    /
    1.00
    Syringe
Forma farmaċewtika:
  • Suspensjoni intramammarja
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        14
        day
      • Milk
        48
        hour
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
  • QJ51RC23
Status tal-awtorizzazzjoni:
  • Surrendered
Authorised in:
Din l-informazzjoni mhijiex disponibbli għal dan il-prodott.
Deskrizzjoni tal-pakkett:

Tagħrif addizzjonali

Entitlement type:
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
  • Intervet (Ireland) Limited
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
  • INTERVET INTERNATIONAL B.V.
Awtorità responsabbli:
  • Health Products Regulatory Authority
Numru tal-awtorizzazzjoni:
  • VPA10996/074/001
Data tal-bidla fl-istatus tal-awtorizzazzjoni:

Dokumenti

Sommarju tal-karatteristiċi tal-prodott

Dan id-dokument ma jeżistix f'dan il-lingwa (Malti). Tista 'ssibha f'lingwa oħra hawn taħt.
English (PDF)
Ippubblikat fuq: 8/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."